Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Terbinafine gel - MediQuest Therapeutics

Drug Profile

Terbinafine gel - MediQuest Therapeutics

Alternative Names: IVR-101; MQX-5866; MQX-5867; Organogel - MediQuest Therapeutics; Organogel of terbinafine 2% or 6%

Latest Information Update: 09 Feb 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MediQuest Therapeutics
  • Developer Ivrea Pharmaceuticals
  • Class Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
  • Mechanism of Action Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Onychomycosis

Most Recent Events

  • 09 Feb 2016 No development reported - Phase-II for Onychomycosis in USA (Topical)
  • 30 May 2013 Biomarkers information updated
  • 28 Aug 2012 Clinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top